Joint Development, Inc.
USPTO PatentsView assignee record - 19 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Joint ranks #15,399 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 5 technology areas.
- #15,399
- of 49,997 US assignees by volume
- 33rd percentile
- by Innovation Score (30.0/100)
- 10.3
- avg claims per patent
- +43%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R15399 · US Corporation #15,399 · 19 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 19 grants
- MID-PACK #15,399/49,997
- PHOTO-FINISH Jeisys Medical
- CPC-NARROW A61F · 5 areas
- INNOV-THIN 30.0/100
- CLAIMS-PAR 10.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-UP +43% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Jeisys Medical Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Joint’s 30.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Joint
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Joint Development · this assignee 30
Joint Development · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Joint's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Joint?
Each dot is one of Joint’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Joint’s own 10.3 claims/patent is at or below the 10.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Joint's grants concentrate
Joint Development, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 42.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, Joint sits between Jeisys Medical Inc. and Kawasaki Railcar Manufacturing Co., Ltd..
Joint's three-year grant acceleration
Joint Development, Inc. shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Joint's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Jeisys Medical
Jeisys Medical Inc.
19 patents
- Jenkem Technology…
JenKem Technology Co., Ltd. (Tianjin)
19 patents
- Jiashan Sansi Opt…
Jiashan Sansi Optoelectronic Technology Co. Ltd.
19 patents
- Johnan Manufactur…
Johnan Manufacturing Inc.
19 patents
- Joint Stock “Scie…
Joint Stock Company “Science and Innovations”
19 patents
- Jumpcloud
JumpCloud, Inc.
19 patents
- Kaken Pharmaceuti…
Kaken Pharmaceutical Co., Ltd.
19 patents
- Kawasaki Railcar…
Kawasaki Railcar Manufacturing Co., Ltd.
19 patents
- Joint Development ◀
Joint Development, Inc.
19 patents
What this shows Joint holds 19 patents at rank #15,398, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Joint
By rank, the assignees closest to #15,398 in granted patent volume.
- Jeisys Medical Inc. #15,394 · 19 patents
- JenKem Technology Co., Ltd. (Tianjin) #15,395 · 19 patents
- Jiashan Sansi Optoelectronic Technology Co. Ltd. #15,396 · 19 patents
- Johnan Manufacturing Inc. #15,397 · 19 patents
- Joint Stock Company “Science and Innovations” #15,399 · 19 patents
- JumpCloud, Inc. #15,400 · 19 patents
- Kaken Pharmaceutical Co., Ltd. #15,401 · 19 patents
- Kawasaki Railcar Manufacturing Co., Ltd. #15,402 · 19 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Joint's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Joint's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 33rd percentile higher than 33% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 5 | 26.3% |
| 2017 | 1 | 5.3% |
| 2019 | 1 | 5.3% |
| 2020 | 3 | 15.8% |
| 2021 | 2 | 10.5% |
| 2022 | 1 | 5.3% |
| 2024 | 4 | 21.1% |
| 2025partial year | 2 | 10.5% |
Which technologies does Joint Development, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Joint Development, Inc.'s patent record in context - here's where to go next.
- Joint Development, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 42.1% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #15,399 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Joint Development, Inc. against Jeisys Medical Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.